SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 20, 2026

ARWR

ARROWHEAD PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $1.2M total
Actionable Insight • Neutral

This cluster is too small to warrant a trading signal. Monitor for any C-suite insider selling or a larger cluster (>0.5% of market cap) that would indicate a more informed bearish view. The next catalyst to watch is the upcoming quarterly earnings report.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$87.11
T+0 close · Aug 20, 2026 · via day close
Latest settled
−49.25%
T+60 · $44.21
Vs SPY
−45.88%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 21 $87.11entry
  2. T+1 · 3mo ago −0.44%α −0.14% · $86.73
  3. T+5 · 3mo ago −2.53%α −3.00% · $84.91
  4. T+20 · 8w ago −21.03%α −22.05% · $68.79
  5. T+60 · 14h ago −49.25%α −45.88% · $44.21
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two directors at Arrowhead Pharmaceuticals sold a combined $1.19M in open-market sales on August 18, 2026. This is a small cluster relative to the $12.6B market cap (0.009%), and both sellers are directors, not C-suite executives, which per academic literature makes cluster sales a weak signal. The sales are likely liquidity-driven and do not indicate a material bearish view on the company's prospects.

Key Financial Metrics

Direction
selling
Total Value
$1.2M
Insiders
2

Key Facts

  • Two directors sold shares on the same day: Michael S. Perry sold 11,600 shares at $87.30 ($1.01M), and Adeoye Y. Olukotun sold 2,000 shares at $86.96 ($174K).
  • Total open-market sales of $1.19M represent only 0.009% of ARWR's $12.6B market cap, well below the 0.1% threshold for materiality.
  • Both sellers are directors, not C-suite executives; insider sales by directors are less informative than sales by the CEO or CFO.
  • No 10b5-1 plan or pattern information is available, but the small size and director status suggest routine portfolio diversification.

Financial Impact

$1.19M in insider sales, representing 0.009% of market cap

insider ownership

Risk Factors

  • Insider sales could accelerate if management becomes concerned about upcoming clinical trial results or regulatory decisions.
  • The stock is highly valued at $12.6B for a pre-commercial biotech; any pipeline setback could trigger significant downside.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARWR-1787292234568

Track record

7 reports on ARWR

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +17.69% at T+5 after the Nov 2, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Bearish 6/10 Entry $47.78 to $44.21 Now $47.78 +0.00% ▲ +7.47% +5.56% vs SPY
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $57.46 to $58.16 Now $47.78 −16.85% ▲ +1.22% +0.91% vs SPY
  3. Nov 4, 202612d ago 8-K Bullish 5/10 Entry $61.65 to $57.46 Now $47.78 −22.50% ▼ −6.80% −2.39% vs SPY
  4. Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $59.53 to $61.65 Now $47.78 +19.74% ▼ −3.56% −1.91% vs SPY
  5. Sep 10, 20269w ago Institutional Cluster Mixed 5/10 Entry $82.76 to $82.85 Now $47.78 −42.27% ▲ +0.11% −0.74% vs SPY
  6. Aug 20, 202612w ago Insider Cluster Neutral 2/10 Viewing Entry $87.11 to $86.73 Now $47.78 −45.15% ▼ −0.44% −0.14% vs SPY
  7. Jun 16, 202621w ago 8-K Neutral 2/10 Entry $81.04 to $81.82 Now $47.78 −41.04% ▲ +0.96% +0.18% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens Wed (12h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 21, 2026